NS5A: A new target for antiviral drugs in the treatment of hepatitis C virus infection

被引：6
作者：
Debes, Jose D. [1 ]
Smith, Coleman I. [1 ]
机构：
[1] Univ Minnesota, Plymouth, MN USA
来源：
HEPATOLOGY | 2012年 / 56卷 / 03期
关键词：
GENOTYPE; 1; PROTEIN; REPLICATION; INHIBITOR; BMS-790052;
D O I：
10.1002/hep.25696
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：797 / 799
页数：3
相关论文
共 50 条
  • [21] Cyclophilin A-independent recruitment of NS5A and NS5B into hepatitis C virus replication complexes
    Chatterji, Udayan
    Bobardt, Michael D.
    Lim, Precious
    Gallay, Philippe A.
    JOURNAL OF GENERAL VIROLOGY, 2010, 91 : 1189 - 1193
  • [22] Computational design of potent dimeric phenylthiazole NS5A inhibitors for hepatitis C virus
    Liman, Wissal
    Oubahmane, Mehdi
    Lahcen, Nouhaila Ait
    Hdoufane, Ismail
    Cherqaoui, Driss
    Daoud, Rachid
    El Allali, Achraf
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [23] Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived from GB Virus A NS5A
    Liu, Xiuying
    Huang, Yibing
    Cheng, Min
    Pan, Ling
    Si, Youhui
    Li, Guirong
    Niu, Yuqiang
    Zhao, Lianjing
    Zhao, Jin
    Li, Xiang
    Chen, Yuxin
    Yang, Wei
    JOURNAL OF VIROLOGY, 2013, 87 (03) : 1649 - 1657
  • [24] Small molecule inhibitors of the hepatitis C virus-encoded NS5A protein
    Belda, Oscar
    Targett-Adams, Paul
    VIRUS RESEARCH, 2012, 170 (1-2) : 1 - 14
  • [25] Epistatic Interactions in NS5A of Hepatitis C Virus Suggest Drug Resistance Mechanisms
    Knops, Elena
    Sierra, Saleta
    Kalaghatgi, Prabhav
    Heger, Eva
    Kaiser, Rolf
    Kalinina, Olga, V
    GENES, 2018, 9 (07):
  • [26] Evolutionary pathways to NS5A inhibitor resistance in genotype 1 hepatitis C virus
    Zhou, Shuntai
    Williford, Sara E.
    McGivern, David R.
    Burch, Christina L.
    Hu, Fengyu
    Benzine, Tiffany
    Ingravallo, Paul
    Asante-Appiah, Ernest
    Howe, Anita Y. M.
    Swanstrom, Ronald
    Lemon, Stanley M.
    ANTIVIRAL RESEARCH, 2018, 158 : 45 - 51
  • [27] Activity of Hexokinase Is Increased by Its Interaction with Hepatitis C Virus Protein NS5A
    Ramiere, Christophe
    Rodriguez, Jonathan
    Enache, Liviu S.
    Lotteau, Vincent
    Andre, Patrice
    Diaz, Olivier
    JOURNAL OF VIROLOGY, 2014, 88 (06) : 3246 - 3254
  • [28] Hepatitis C Virus NS5B and Host Cyclophilin A Share a Common Binding Site on NS5A
    Rosnoblet, Claire
    Fritzinger, Bernd
    Legrand, Dominique
    Launay, Helene
    Wieruszeski, Jean-Michel
    Lippens, Guy
    Hanoulle, Xavier
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (53) : 44249 - 44260
  • [29] Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection
    Link, John O.
    Taylor, James G.
    Xu, Lianhong
    Mitchell, Michael
    Guo, Hongyan
    Liu, Hongtao
    Kato, Darryl
    Kirschberg, Thorsten
    Sun, Jianyu
    Squires, Neil
    Parrish, Jay
    Keller, Terry
    Yang, Zheng-Yu
    Yang, Chris
    Matles, Mike
    Wang, Yujin
    Wang, Kelly
    Cheng, Guofeng
    Tian, Yang
    Mogalian, Erik
    Mondou, Elsa
    Cornpropst, Melanie
    Perry, Jason
    Desai, Manoj C.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (05) : 2033 - 2046
  • [30] Antiviral Activity and Resistance Analysis of NS3/4A Protease Inhibitor Grazoprevir and NS5A Inhibitor Elbasvir in Hepatitis C Virus GT4 Replicons
    Asante-Appiah, Ernest
    Curry, Stephanie
    McMonagle, Patricia
    Ingravallo, Paul
    Chase, Robert
    Nickle, David
    Qiu, Ping
    Howe, Anita
    Lahser, Frederick C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (07)
12345